全文获取类型
收费全文 | 306006篇 |
免费 | 26527篇 |
国内免费 | 6892篇 |
专业分类
耳鼻咽喉 | 4064篇 |
儿科学 | 5832篇 |
妇产科学 | 4647篇 |
基础医学 | 26333篇 |
口腔科学 | 9112篇 |
临床医学 | 33896篇 |
内科学 | 29782篇 |
皮肤病学 | 3019篇 |
神经病学 | 21927篇 |
特种医学 | 9158篇 |
外国民族医学 | 13篇 |
外科学 | 28119篇 |
综合类 | 46985篇 |
现状与发展 | 16篇 |
一般理论 | 30篇 |
预防医学 | 42505篇 |
眼科学 | 2974篇 |
药学 | 29838篇 |
646篇 | |
中国医学 | 28705篇 |
肿瘤学 | 11824篇 |
出版年
2024年 | 787篇 |
2023年 | 5783篇 |
2022年 | 8977篇 |
2021年 | 14759篇 |
2020年 | 14361篇 |
2019年 | 14887篇 |
2018年 | 13527篇 |
2017年 | 12207篇 |
2016年 | 11339篇 |
2015年 | 10614篇 |
2014年 | 21039篇 |
2013年 | 22581篇 |
2012年 | 18636篇 |
2011年 | 19945篇 |
2010年 | 15907篇 |
2009年 | 14231篇 |
2008年 | 13609篇 |
2007年 | 13399篇 |
2006年 | 11511篇 |
2005年 | 9823篇 |
2004年 | 8089篇 |
2003年 | 7169篇 |
2002年 | 5614篇 |
2001年 | 4768篇 |
2000年 | 4141篇 |
1999年 | 3382篇 |
1998年 | 2907篇 |
1997年 | 2674篇 |
1996年 | 2249篇 |
1995年 | 2093篇 |
1994年 | 1964篇 |
1993年 | 1697篇 |
1992年 | 1590篇 |
1991年 | 1435篇 |
1990年 | 1230篇 |
1989年 | 1140篇 |
1988年 | 1097篇 |
1987年 | 1018篇 |
1986年 | 916篇 |
1985年 | 2290篇 |
1984年 | 2515篇 |
1983年 | 1563篇 |
1982年 | 2004篇 |
1981年 | 1454篇 |
1980年 | 1257篇 |
1979年 | 1067篇 |
1978年 | 886篇 |
1977年 | 684篇 |
1976年 | 788篇 |
1975年 | 532篇 |
排序方式: 共有10000条查询结果,搜索用时 344 毫秒
101.
102.
癫痫作为多种病因引起的神经系统慢性、发作性疾病,严重影响着患者的生活质量,因此对其及时诊断和早期治疗极为重要。目前已有多种神经影像技术用于癫痫的定位、定侧和病理生理研究。弥散张量成像是利用水分子在组织中弥散的各向异性成像的磁共振技术,是目前唯一能在活体中无创性地显示脑白质纤维束的方法,它能敏感地显示脑部细微结构,并能揭示各个结构间的功能联系,有助于癫痫的研究。本文主要从癫痫的病因诊断、癫痫手术的辅助指导、癫痫的结构网络及其与癫病功能障碍的相关性研究等方面对DTI应用于癫痫的最新研究进展进行综述。 相似文献
103.
104.
近10年来,甲状腺外科快速发展。随着甲状腺外科相关指南、专家共识的不断修订与完善,在专业团体的引导下,中国甲状腺外科在术前诊断、手术方式、治疗方法创新等方面实现了可喜发展,病人5年生存率明显提高。甲状腺疾病诊治技术快速革新、外科术式的发展与统一、多学科诊疗模式发展与应用、术后规范化管理助力疗效提高、重视特殊情况下的甲状腺癌及髓样癌诊治以及质量控制体系的建立与完善等综合发展提升了甲状腺癌诊疗的安全性、精准性,有效的改善了病人生活质量、延长生存时间,为建设健康中国贡献力量。 相似文献
105.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
106.
《Surgery (Oxford)》2020,38(10):596-600
Improving Surgical Training is a programme piloting an innovative, evidence-based approach to training. It was developed in response to the Shape of Training report which reviewed postgraduate training and recommended changes in medical education to meet the demands of the modern NHS. A series of initiatives have been developed to enhance the experience for surgical trainees not only to encourage a more focussed and supported method, but also to improve their job satisfaction. The initiatives have combined a greater emphasis on time for training provided by trainers with allocated time for training with multidisciplinary teamworking and the use of technology enhanced learning with simulation of both technical and non-technical skills. The pilot started in 2018 with core training in general surgery and has been expanded to include vascular surgery, urology and trauma and orthopaedics over the last 2 years. Initial feedback from both trainees, trainers and schools of surgery have identified different challenges to aid implementation. The programme is being very carefully evaluated by an independent company as well as careful oversight by the General Medical Council which are paramount to its success. 相似文献
107.
108.
109.
Yesim Aydinok 《ISBT科学丛刊》2020,15(1):102-109
Lifetime red cell concentrate (RCC) transfusions still account for significant iron overload‐related morbidity and mortality despite chelation therapy in thalassaemia. The cumulative risk of transfusion‐transmitted infections is substantial for thalassaemia patients. Pathogen reduction technologies for RCC may imply a proactive approach against new/re‐emerging pathogens and may be an ultimate safeguard for transfusion safety in the developing countries. Red cell alloimmunization may become a significant clinical challenge in thalassaemia. The availability of high‐throughput molecular blood group antigen typing in the donors may allow perfect match transfusion, beyond ABO‐D and CEK antigen‐matched transfusions. Allogeneic stem cell transplantation (A‐SCT) is the only available curative therapy in thalassaemia, but carries a substantial risk of serious adverse events and mortality. Gene addition therapy for correction of the α‐globin chain imbalance overcomes the problems of donor availability and immunological complications of A‐SCT. Gene editing by either gene disruption or correction emerged as a potential alternative to gene addition therapy in beta‐thalassaemia. A new era of novel therapeutics targeting α/β imbalance, ineffective erythropoiesis or iron dysregulation is unfolding in thalassaemia management, and a number of those now have agents in preclinical and clinical development. Hydroxyurea (HU) may improve globin chain imbalance and be beneficial for reducing or omitting transfusion requirement. Ruxolitinib has allowed steady decrease in spleen volume that may serve for avoiding splenectomy in beta‐thalassaemia. Luspatercept may restore normal erythroid differentiation and improve anaemia. Hepcidin mimetics or TMPRSS6 inhibitors may modulate ineffective erythropoiesis by iron restriction and improve anaemia and organ iron loading. 相似文献
110.
《European journal of medical genetics》2020,63(9):103981
Congenital diarrhea and enteropathies (CODEs) are a group of monogenic disorders that often present with severe diarrhea in the first weeks of life. Enteric anendocrinosis (EA), an extremely rare cause of CODE, is characterized by a marked reduction of intestinal enteroendocrine cells (EC). EA is associated with recessively inherited variants in Neurogenin-3 (NEUROG3) gene. Here we investigate a case of a male infant who presented with mysterious severe malabsorptive diarrhea since birth. Thorough clinical assessments and laboratory tests were successful to exclude the majority of differential diagnosis categories. However, the patient's diagnosis was not established until the genetic test using whole-exome sequencing (WES) was performed. We identified a novel homozygous missense disease-causing variant (DCV) in NEUROG3 (c.413C>G, p.Thr138Arg). Moreover, molecular dynamic simulation analysis showed that (p.Thr138Arg) led to a global change of the NEUROG3 orientation affecting its DNA binding capacity. To the best of our knowledge, this is the first time to apply WES to reach a differential diagnosis of patients with CODEs. Our study not only expands our knowledge about NEUROG3 variants and their clinical consequences but also proves that WES is a very effective tool for the diagnosis of CODEs. This might be of value in early diagnosis of diseases and prenatal CODEs detection. 相似文献